Alibaba Health Information Technology Limited Stock
Stocks
241
BMG0171K1018
Drug Retailers
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.450 HKD | +2.68% |
|
+1.47% | -31.68% |
| 06-29 | Chinese Biopharma Stocks Rally as Investors Favor Healthcare Over AI | DJ |
| 05-26 | Alibaba Health is Winning Battles but Losing the War |  |
| Market Cap | 46.91B 54.31B 6.93B 6.06B 5.59B 5.14B 9.73B 667B 9.9B 66.72B 26.18B 326B 26.02B 25.45B 1,123B | P/E 2027 * |
22.9x | P/E 2028 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 34.92B 40.42B 5.16B 4.51B 4.16B 3.82B 7.24B 496B 7.37B 49.65B 19.48B 243B 19.37B 18.94B 836B | EV / Sales 2027 * |
0.9x | EV / Sales 2028 * | 0.75x |
| Free-Float |
36.47% | Yield 2027 * |
0.99% | Yield 2028 * | 1.24% |
| 1 day | +2.68% | ||
| 1 week | +1.47% | ||
| Current month | +12.01% | ||
| 1 month | +0.58% | ||
| 3 months | -27.22% | ||
| 6 months | -49.26% | ||
| Current year | -31.68% |
| 1 week | 3.16 |  | 3.57 |
| 1 month | 3.04 | | 3.57 |
| Current year | 3.04 | | 7.91 |
| 1 year | 3.04 | | 7.91 |
| 3 years | 2.59 | | 7.91 |
| 5 years | 2.59 | | 15.56 |
| 10 years | 2.59 | | 30.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CEO | Chief Executive Officer | 47 | 28/11/2023 |
Meng Yue Sheng
DFI | Director of Finance/CFO | 44 | 15/05/2026 |
Hua Zhang
HRO | Human Resources Officer | - | 01/02/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Di Fan Shen
CHM | Chairman | 47 | 15/12/2025 |
Yi Fei Huang
BRD | Director/Board Member | 52 | 09/06/2019 |
Jiaojiao Huang
BRD | Director/Board Member | 44 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 13/06/25 | Other | Chief Financial Officer | 453,600 | 0.0028% | ||
| 13/06/25 | Other | Chief Executive Officer | 2,381,400 | 0.0148% | ||
| 18/06/24 | Other | Chief Executive Officer | 164,883 | 0.0010% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.68% | +1.47% | -25.32% | -31.00% | 6.81B | |
| +2.77% | +5.75% | -15.44% | -25.55% | 15.05B | |
| -0.16% | -1.06% | -21.61% | -6.94% | 5.95B | |
| +0.52% | +6.03% | -7.94% | -29.93% | 3.82B | |
| -2.18% | +8.09% | +12.51% | -29.10% | 3.31B | |
| -0.33% | -1.94% | -28.98% | -48.09% | 3.16B | |
| +3.36% | +0.01% | -37.82% | -12.38% | 3.12B | |
| +0.76% | -1.04% | +94.50% | - | 2.51B | |
| +1.56% | -2.35% | -23.92% | -1.72% | 2.48B | |
| 0.00% | +0.87% | +0.90% | +35.19% | 1.7B | |
| Average | +0.91% | +1.34% | -5.31% | -16.61% | 4.79B | |
| Weighted average by Cap. | +1.47% | +1.49% | -11.53% | -21.64% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 38.6B 44.69B 5.7B 4.98B 4.6B 4.23B 8.01B 549B 8.14B 54.89B 21.54B 268B 21.41B 20.94B 924B | 42.64B 49.37B 6.3B 5.51B 5.08B 4.67B 8.85B 606B 9B 60.65B 23.8B 296B 23.65B 23.13B 1,021B |
| Net income | 2.09B 2.43B 309M 271M 250M 229M 435M 29.77B 442M 2.98B 1.17B 14.55B 1.16B 1.14B 50.16B | 2.61B 3.03B 386M 338M 311M 286M 542M 37.15B 552M 3.72B 1.46B 18.16B 1.45B 1.42B 62.58B |
| Net Debt | -12B -13.89B -1.77B -1.55B -1.43B -1.31B -2.49B -170B -2.53B -17.06B -6.69B -83.33B -6.65B -6.51B -287B | -15.1B -17.48B -2.23B -1.95B -1.8B -1.65B -3.13B -215B -3.19B -21.47B -8.42B -105B -8.37B -8.19B -361B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | HK$3.450 | +2.68% | 36,961,668 |
| 15/07/26 | HK$3.360 | +1.82% | 127,945,898 |
| 14/07/26 | HK$3.300 | -1.49% | 282,675,842 |
| 13/07/26 | HK$3.350 | -3.46% | 156,593,303 |
| 10/07/26 | HK$3.470 | +2.06% | 131,278,962 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 241 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition